KVA12123,Pembrolizumab
kineta bio,Merck
['biomarker', 'kva12123']
$ka up 12.99% at $4.35 (volume 67k, avgvolume 23k) in the last 20 min latest news: 6:30 am edt today
kineta unveils new vista biomarker data and kva12123 phase 1/2 clinical trial update at aacr annual meeting 2023 
Real-time penny stock alerts based on trading algorithms and breaking news; buy the dips and sell the rips.

Visit our website for more details.